×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CERO – cero therapeutics holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CERO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
07:30 am
cero
CERo Therapeutics Announces Trading on OTCQB Market
High
Report
CERo Therapeutics Announces Trading on OTCQB Market
11/25
07:12 am
cero
Aggressive cancer warning signs revealed after JFK's granddaughter's diagnosis [FOX News]
Medium
Report
Aggressive cancer warning signs revealed after JFK's granddaughter's diagnosis [FOX News]
11/20
06:02 am
cero
CERo Therapeutics (NASDAQ:CERO) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
High
Report
CERo Therapeutics (NASDAQ:CERO) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
11/18
12:41 pm
cero
CERo Therapeutics (NASDAQ:CERO) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
Low
Report
CERo Therapeutics (NASDAQ:CERO) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
11/5
08:00 am
cero
CERo Therapeutics Initiates Second Cohort of Phase 1 Clinical Trial of CER-1236 in AML with Patient Receiving Significant Increase in Dosing
Medium
Report
CERo Therapeutics Initiates Second Cohort of Phase 1 Clinical Trial of CER-1236 in AML with Patient Receiving Significant Increase in Dosing
11/4
10:11 am
cero
CERo Therapeutics to Present Data at the Society for Immunotherapy of Cancer Conference Highlighting Lead Compound CER-1236 Sustained Cell Expansion and Cytokine Response [Yahoo! Finance]
High
Report
CERo Therapeutics to Present Data at the Society for Immunotherapy of Cancer Conference Highlighting Lead Compound CER-1236 Sustained Cell Expansion and Cytokine Response [Yahoo! Finance]
11/4
09:05 am
cero
CERo Therapeutics to Present Data at the Society for Immunotherapy of Cancer Conference Highlighting Lead Compound CER-1236 Sustained Cell Expansion and Cytokine Response
High
Report
CERo Therapeutics to Present Data at the Society for Immunotherapy of Cancer Conference Highlighting Lead Compound CER-1236 Sustained Cell Expansion and Cytokine Response
11/3
02:28 pm
cero
CERo Therapeutics (NASDAQ:CERO) had its "hold" rating reaffirmed by analysts at Maxim Group.
Medium
Report
CERo Therapeutics (NASDAQ:CERO) had its "hold" rating reaffirmed by analysts at Maxim Group.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/2
05:18 pm
cero
Form 424B3 CERO THERAPEUTICS HOLDIN
Medium
Report
Form 424B3 CERO THERAPEUTICS HOLDIN
12/2
05:17 pm
cero
Form 424B3 CERO THERAPEUTICS HOLDIN
Medium
Report
Form 424B3 CERO THERAPEUTICS HOLDIN
12/2
04:10 pm
cero
Form DEFA14A CERO THERAPEUTICS HOLDIN
Medium
Report
Form DEFA14A CERO THERAPEUTICS HOLDIN
12/2
08:30 am
cero
Form 8-K CERO THERAPEUTICS HOLDIN For: Nov 26
High
Report
Form 8-K CERO THERAPEUTICS HOLDIN For: Nov 26
11/28
08:31 am
cero
Form DEF 14A CERO THERAPEUTICS HOLDIN For: Dec 19
High
Report
Form DEF 14A CERO THERAPEUTICS HOLDIN For: Dec 19
11/20
04:05 pm
cero
Form 424B3 CERO THERAPEUTICS HOLDIN
Medium
Report
Form 424B3 CERO THERAPEUTICS HOLDIN
11/20
04:05 pm
cero
Form 424B3 CERO THERAPEUTICS HOLDIN
Medium
Report
Form 424B3 CERO THERAPEUTICS HOLDIN
11/19
04:10 pm
cero
Form 10-Q CERO THERAPEUTICS HOLDIN For: Sep 30
High
Report
Form 10-Q CERO THERAPEUTICS HOLDIN For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: